Equity Research

Featured Research

equity development
Tristel Plc
Tristel develops proprietary infection, hygiene and contamination control products used by: Human Healthcare (branded Tristel, 85% of sales); Contamination Control (Crystel, 9%), and Animal care (...
edison investment research
WANdisco plc
While the wait for further major big data deals goes on, a number of deals are still expected to close this year and the company continues to make impressive progress in entrenching itself within the...
equity development
Tiziana Life Sciences PLC
Tiziana Life Sciences (TILS) has identified a potential 'master regulator' for metastatic breast cancer (mBC). 'Bcl-3 inhibition' would be a novel strategy for treatment,...